Sabra Healthcare REIT Inc (SBRA) concluded trading on Thursday at a closing price of $18.35, with 3.57 million shares of worth about $65.52 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 29.13% during that period and on September 12, 2024 the price saw a gain of about 2.34%. Currently the company’s common shares owned by public are about 231.27M shares, out of which, 230.43M shares are available for trading.
Stock saw a price change of 5.22% in past 5 days and over the past one month there was a price change of 12.37%. Year-to-date (YTD), SBRA shares are showing a performance of 28.59% which increased to 40.27% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $12.83 but also hit the highest price of $17.98 during that period. The average intraday trading volume for Sabra Healthcare REIT Inc shares is 2.18 million. The stock is currently trading 9.22% above its 20-day simple moving average (SMA20), while that difference is up 11.81% for SMA50 and it goes to 24.82% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sabra Healthcare REIT Inc (NASDAQ: SBRA) currently have 231.27M outstanding shares and institutions hold larger chunk of about 92.06% of that.
The stock has a current market capitalization of $4.30B and its 3Y-monthly beta is at 1.22. PE ratio of stock for trailing 12 months is 82.18, while it has posted earnings per share of $0.22 in the same period. Its PEG reads 11.26 while making debt-to-equity ratio of 0.90. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SBRA, volatility over the week remained 2.39% while standing at 1.95% over the month.
Stock’s fiscal year EPS is expected to rise by 798.48% while it is estimated to increase by 24.95% in next year. EPS is likely to grow at an annualized rate of 7.30% for next 5-years, compared to annual growth of -47.68% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Deutsche Bank on January 30, 2024 offering a Buy rating for the stock and assigned a target price of $21 to it. Coverage by BMO Capital Markets stated Sabra Healthcare REIT Inc (SBRA) stock as a Market perform in their note to investors on October 17, 2023, suggesting a price target of $16 for the stock. On October 16, 2023, Wells Fargo Upgrade their recommendations, while on October 10, 2023, BofA Securities Upgrade their ratings for the stock with a price target of $16. Stock get an Outperform rating from Wedbush on October 03, 2023.
